Salta al contenido principal
evirtual
  • Página Principal
  • Más
En este momento está usando el acceso para invitados
Acceder
evirtual
Página Principal
Expandir todo Colapsar todo
  1. Garantía de Calidad de Medicamentos
  2. Material de Interés
  3. Impurezas Farmacéuticas

Impurezas Farmacéuticas

Requisitos de finalización
    • A Review on Impurity Profile in Pharmaceutical Substances.pdf A Review on Impurity Profile in Pharmaceutical Substances.pdf
    • A REVIEW ON PHARMACEUTICAL IMPURITIES AND THEIR importance.pdf A REVIEW ON PHARMACEUTICAL IMPURITIES AND THEIR importance.pdf
    • A Review on Significances of Impurity Profiling.aspx A Review on Significances of Impurity Profiling.aspx
    • Advance approaches for the impurity profiling of pharmaceutical drugs.pdf Advance approaches for the impurity profiling of pharmaceutical drugs.pdf
    • Assessment of Genotoxic Impurities in Small Molecule Drug Candidates.pdf Assessment of Genotoxic Impurities in Small Molecule Drug Candidates.pdf
    • Brief About Impurity Profiling.pdf Brief About Impurity Profiling.pdf
    • Determination of elemental impurities in pharmaceutical products.pdf Determination of elemental impurities in pharmaceutical products.pdf
    • Drug impurity profiling strategies.pdf Drug impurity profiling strategies.pdf
    • Elemental Impurities USP.pdf Elemental Impurities USP.pdf
    • Elemental Impurities—Limits.pdf Elemental Impurities—Limits.pdf
    • Elemental impurities.pdf Elemental impurities.pdf
    • Establishing Impurity Acceptance Criteria As Part of Specifications for NDAs.pdf Establishing Impurity Acceptance Criteria As Part of Specifications for NDAs.pdf
    • FDA Perspective and Expectations for Control of Elemental Impurities in Drug Products.pdf FDA Perspective and Expectations for Control of Elemental Impurities in Drug Products.pdf
    • From Heavy Metals Testing to the Measurement of Elemental Impurities in Pharmaceuticals.pdf From Heavy Metals Testing to the Measurement of Elemental Impurities in Pharmaceuticals.pdf
    • Genotoxic and non-genotoxic impurities in pharmaceuticals.pdf Genotoxic and non-genotoxic impurities in pharmaceuticals.pdf
    • Genotoxic Impurities Part 2 Toxicological Overview.pdf Genotoxic Impurities Part 2 Toxicological Overview.pdf
    • Harmonized-guideline-on-limit-and-testing-of-elemental-impurities-inpharmaceutical-substances.pdf Harmonized-guideline-on-limit-and-testing-of-elemental-impurities-inpharmaceutical-substances.pdf
    • Identification of Pharmaceutical Impurities.pdf Identification of Pharmaceutical Impurities.pdf
    • Impurity Deficiencies How FDA Can Refuse-to-Receive an ANDA.pdf Impurity Deficiencies How FDA Can Refuse-to-Receive an ANDA.pdf
    • Impurity Pharma Market and Importance.pdf Impurity Pharma Market and Importance.pdf
    • Impurity profile Significance in Active Pharmaceutical ingredient.pdf Impurity profile Significance in Active Pharmaceutical ingredient.pdf
    • Impurity profiling - a necessity in the pharma industry.pdf Impurity profiling - a necessity in the pharma industry.pdf
    • Impurity profiling an emerging trend in Pharmaceuticals.pdf Impurity profiling an emerging trend in Pharmaceuticals.pdf
    • Impurity Profiling of Drugs towards Safety and Efficacy.pdf Impurity Profiling of Drugs towards Safety and Efficacy.pdf
    • Impurity Profiling Theory and Practice.pdf Impurity Profiling Theory and Practice.pdf
    • impurity-profiling-of-active-pharmaceutical-ingredients-and-finished-drug-products.pdf impurity-profiling-of-active-pharmaceutical-ingredients-and-finished-drug-products.pdf
    • impurity-profiling-of-active-pharmaceutical-ingredients.pdf impurity-profiling-of-active-pharmaceutical-ingredients.pdf
    • Introduction to drug impurities and their quantification in pharmaceutical dosage.pdf Introduction to drug impurities and their quantification in pharmaceutical dosage.pdf
    • Monitoring Pharmaceutical Impurities.pdf Monitoring Pharmaceutical Impurities.pdf
    • Organic-volatile-impurities-in-pharmaceuticals.pdf Organic-volatile-impurities-in-pharmaceuticals.pdf
    • Pharmaceutical Impurities A Review.pdf Pharmaceutical Impurities A Review.pdf
    • PHARMACEUTICAL IMPURITIES AND THEIR CHARACTERIZATION.pdf PHARMACEUTICAL IMPURITIES AND THEIR CHARACTERIZATION.pdf
    • PRESENCE OF ORGANIC IMPURITIES INTO ACTIVE PHARMACEUTICAL INGREDIENTS.pdf PRESENCE OF ORGANIC IMPURITIES INTO ACTIVE PHARMACEUTICAL INGREDIENTS.pdf
    • presentation-implementation-ich-q3d-guideline.pdf presentation-implementation-ich-q3d-guideline.pdf
    • Recent trends in impurity profiling of pharmaceutical products.pdf Recent trends in impurity profiling of pharmaceutical products.pdf
    • Safety Based Limits for the Control of Impurities.pdf Safety Based Limits for the Control of Impurities.pdf
    • Scientific Approaches for Impurity Profiling.pdf Scientific Approaches for Impurity Profiling.pdf
En este momento está usando el acceso para invitados (Acceder)
Resumen de retención de datos
Desarrollado por Moodle
Moodle Appliance - Powered by TurnKey Linux